These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826 [No Abstract] [Full Text] [Related]
6. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study. Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446 [No Abstract] [Full Text] [Related]
11. The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. McNally PG; Walls J; Feehally J Nephrol Dial Transplant; 1990; 5(11):962-8. PubMed ID: 2127834 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine-induced renal dysfunction in human renal allograft recipients. Kiberd BA Transplantation; 1989 Dec; 48(6):965-9. PubMed ID: 2688208 [TBL] [Abstract][Full Text] [Related]
13. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807 [No Abstract] [Full Text] [Related]
14. Effect of nifedipine on renal allograft function and survival beyond one year. Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239 [TBL] [Abstract][Full Text] [Related]
15. Does nifedipine ameliorate cyclosporin A nephrotoxicity? Kwan JT; Foxall PJ; Townend JN; Bending MR; Eisinger AJ Br Med J (Clin Res Ed); 1987 Oct; 295(6602):851. PubMed ID: 3119066 [No Abstract] [Full Text] [Related]
16. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients. Howard RL; Shapiro JI; Babcock S; Chan L Ren Fail; 1990; 12(2):89-92. PubMed ID: 2236731 [TBL] [Abstract][Full Text] [Related]
17. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients. Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172 [TBL] [Abstract][Full Text] [Related]
18. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation. Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709 [TBL] [Abstract][Full Text] [Related]
19. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation. Kootte AM; Lensen LM; van Bockel JH; Paul LC Transplant Proc; 1988 Jun; 20(3 Suppl 3):136-9. PubMed ID: 3291227 [No Abstract] [Full Text] [Related]
20. Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics. Legault L; Ogilvie RI; Cardella CJ; Leenen FH Can J Cardiol; 1993 Jun; 9(5):398-404. PubMed ID: 8348391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]